SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
37 hedge funds and large institutions have $70.8M invested in Sinovac Biotech, Ltd in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
37
Holding in Top 10
–
Calls
$119K
Puts
–
Top Buyers
| 1 | +$2.15M | |
| 2 | +$786K | |
| 3 | +$365K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$358K |
| 5 |
GP
GLG Partners
London,
United Kingdom
|
+$343K |
Top Sellers
| 1 | -$3.93M | |
| 2 | -$417K | |
| 3 | -$230K | |
| 4 |
VAM
Verity Asset Management
Durham,
North Carolina
|
-$175K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$155K |